In recent years, there has been a rapid upsurge in pharmaceutical and biotechnology contract manufacturing. While experts predict that the global CMO market value will exceed $60 billion by 2018, effective quality oversight and risk management have become more crucial than ever when ensuring successful partnerships and GMP compliance.

The 5th CMO Quality Oversight and Risk Management Summit will bring together industry innovators to connect and discuss the latest outsourcing trends and hot button issues in pharmaceutical, biotechnology and medical device contract manufacturing.

Designed to optimize partnerships between pharma companies and CMO, the Summit serves as a networking platform while offering professionals vital information on how to strategically navigate the outsourcing space. Participants will learn best practices to effectively oversee and manage external manufacturers, tips on utilizing Big Data analytics to improve CMO results, the newest FDA policies and their impact on CMO partnerships, effective risk management strategies to help pharma companies get the best bang for their buck, the latest outsourcing trends, and additional regulatory challenges.